Drug’s public procurement study

Drug’s public procurement study

Dr. Solà-Morales Serra has participated in the formulation of a new study that explains the innovative approach of drug’s public procurement. This study analyses the sharing agreements, and the payments in exchange of results. The study provides also an indicative guide that helps to identify which approach or approaches are the most recommended to each situation. The study describes too, the most used solutions in the European industry. The study is available in the following web address: http://www.ieseinsight.com/fichaMaterial.aspx?pk=139748&idi=1&origen=3&ar=7&buscador=2&keywords=&autores=&titulo=&referencia=&fPublicacionMesInf=&fPublicacionAnyoInf=&fPublicacionMesSup=&fPublicacionAnyoSup=&idiomaB=&idiomaBT=&area=&tipo=&tipoT=&deps=&publicadoPor=&catedra=CRHIM+-+Center+for+Research+in+Healthcare+Innovation+Management  ...
Third workshop on drugs pricing in Milan

Third workshop on drugs pricing in Milan

The objective of this workshop was achieving a multistakeholder work table discussing about issues related to drugs pricing, focusing the horizon scanning, access to innovation, current and future role of insurances and private providers. This seminar was hold the 4th and 5th of May, 2017 in Mila, Italy, by maprovider . Where Dr. Oriol Solà-Morales gave a talk regarding the decentralized HTA process I the case of...